MaxCyte (LON:MXCT)

MaxCyte (LON:MXCT)


Share Price
187.50 p
Change
0 (0.00 %)
Market Cap
£107.42 m
Proactive Investors - Run By Investors For Investors

MaxCyte

We are a U.S.-based global company driving the acceleration of the discovery/development, manufacturing and commercialization of next-generation, cell-based medicines.

We provide our patented, high-performance cell-engineering platform to biopharmaceutical partners engaged in drug discovery and development, biomanufacturing and cell therapy, including gene editing and immuno-oncology....

EPIC: MXCT
Market: AIM:MXCT
52-week High/Low: 254.00p / 175.00p
Sector: Pharma & Biotech
Market Cap: £107.42 m
Website: www.maxcyte.com
col 3
col 4
col 5
col 6

Big Picture – A Deep Dive Examination of MaxCyte


MaxCyte Timeline

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use